DK0531447T3 - Præparater og fremgangsmåder til modulering af RNA-aktivitet ved modifikation af 5'-cap-strukturen af RNA - Google Patents

Præparater og fremgangsmåder til modulering af RNA-aktivitet ved modifikation af 5'-cap-strukturen af RNA

Info

Publication number
DK0531447T3
DK0531447T3 DK91911934T DK91911934T DK0531447T3 DK 0531447 T3 DK0531447 T3 DK 0531447T3 DK 91911934 T DK91911934 T DK 91911934T DK 91911934 T DK91911934 T DK 91911934T DK 0531447 T3 DK0531447 T3 DK 0531447T3
Authority
DK
Denmark
Prior art keywords
rna
cap structure
methods
modifying
compositions
Prior art date
Application number
DK91911934T
Other languages
Danish (da)
English (en)
Inventor
Brenda F Baker
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0531447T3 publication Critical patent/DK0531447T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91911934T 1990-05-23 1991-05-22 Præparater og fremgangsmåder til modulering af RNA-aktivitet ved modifikation af 5'-cap-strukturen af RNA DK0531447T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52759990A 1990-05-23 1990-05-23
PCT/US1991/003606 WO1991017755A1 (en) 1990-05-23 1991-05-22 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna

Publications (1)

Publication Number Publication Date
DK0531447T3 true DK0531447T3 (da) 2000-03-27

Family

ID=24102143

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91911934T DK0531447T3 (da) 1990-05-23 1991-05-22 Præparater og fremgangsmåder til modulering af RNA-aktivitet ved modifikation af 5'-cap-strukturen af RNA

Country Status (15)

Country Link
EP (1) EP0531447B1 (el)
JP (1) JPH06500075A (el)
KR (1) KR960004931B1 (el)
AT (1) ATE186464T1 (el)
AU (1) AU649458B2 (el)
BR (1) BR9106486A (el)
CA (1) CA2083377C (el)
DE (1) DE69131773T2 (el)
DK (1) DK0531447T3 (el)
ES (1) ES2139578T3 (el)
FI (1) FI925210A0 (el)
GR (1) GR3032457T3 (el)
HU (1) HUT63568A (el)
NO (1) NO924309L (el)
WO (1) WO1991017755A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789573A (en) * 1990-08-14 1998-08-04 Isis Pharmaceuticals, Inc. Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
WO1994022488A1 (en) * 1993-04-01 1994-10-13 Isis Pharmaceuticals, Inc. ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION
IL114235A0 (en) * 1994-07-14 1995-10-31 Schering Ag Oligonucleotide conjugates and processes for noninvasive diagnosis utilizing the same
US6380169B1 (en) * 1994-08-31 2002-04-30 Isis Pharmaceuticals, Inc. Metal complex containing oligonucleoside cleavage compounds and therapies
US5962271A (en) * 1996-01-03 1999-10-05 Cloutech Laboratories, Inc. Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
EP1263986A4 (en) * 2000-02-25 2005-02-23 Tao Biosciences Llc Platform for the identification of bacterial genes which are used in the modification of RNA
BRPI0923225A2 (pt) 2008-12-02 2016-10-04 Chiralgen Ltd metodo para sintese de acidos nucleicos modificados no atomo de fosforo
KR101885383B1 (ko) 2009-07-06 2018-08-03 웨이브 라이프 사이언시스 리미티드 신규한 핵산 프로드러그 및 그의 사용 방법
JP5868324B2 (ja) 2010-09-24 2016-02-24 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ 不斉補助基
CN103796657B (zh) 2011-07-19 2017-07-11 波涛生命科学有限公司 合成官能化核酸的方法
SG11201500239VA (en) 2012-07-13 2015-03-30 Wave Life Sciences Japan Asymmetric auxiliary group
EP4219516A3 (en) 2012-07-13 2024-01-10 Wave Life Sciences Ltd. Chiral control
EP2873674B1 (en) 2012-07-13 2020-05-06 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
WO2015108047A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
KR102423317B1 (ko) 2014-01-16 2022-07-22 웨이브 라이프 사이언시스 리미티드 키랄 디자인

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
AU651569B2 (en) * 1990-01-11 1994-07-28 Isis Pharmaceuticals, Inc. Compositions and methods for detecting and modulating RNA activity and gene expression

Also Published As

Publication number Publication date
HUT63568A (en) 1993-09-28
ES2139578T3 (es) 2000-02-16
KR930700118A (ko) 1993-03-13
NO924309D0 (no) 1992-11-09
CA2083377C (en) 2002-11-26
EP0531447A1 (en) 1993-03-17
AU649458B2 (en) 1994-05-26
HU9203659D0 (en) 1993-04-28
EP0531447B1 (en) 1999-11-10
BR9106486A (pt) 1993-05-25
ATE186464T1 (de) 1999-11-15
AU8080291A (en) 1991-12-10
DE69131773T2 (de) 2000-03-02
EP0531447A4 (en) 1993-08-11
WO1991017755A1 (en) 1991-11-28
KR960004931B1 (ko) 1996-04-18
NO924309L (no) 1992-11-09
FI925210A (fi) 1992-11-17
GR3032457T3 (en) 2000-05-31
DE69131773D1 (de) 1999-12-16
JPH06500075A (ja) 1994-01-06
FI925210A0 (fi) 1992-11-17
CA2083377A1 (en) 1991-11-24

Similar Documents

Publication Publication Date Title
DK0531447T3 (da) Præparater og fremgangsmåder til modulering af RNA-aktivitet ved modifikation af 5'-cap-strukturen af RNA
PL334530A1 (en) Novel genes specific in respect to n-axecetyl-l-phosphotricin, used to code amino acids deacetylase, their isolation and application
ATE230439T1 (de) Gezielte gentherapie
DK0672180T3 (da) Oligonukleotidmodulering af protein kinase C
DE69634698D1 (de) Gewebespezifische und ziel-rna-spezifische ribozyme
EP0240332A3 (en) Virus resistant plants having antisense rna
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
DE69333812D1 (de) Endo-Xyloglucan-Transferase
DE19681032D2 (de) Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen
ATE209683T1 (de) Planze resistent gegen mindestens zwei viren und dessen preparation
ATE218372T1 (de) Antisense oligonnukleotide die mit der mrna cap aktivität interferieren und die translation inhibieren
DK268589A (da) Fremgangsmaade til inaktivering af rekombinant dna
ATE232731T1 (de) Verwendung der gensequenz eines promotors zur behandlung rheumatischer erkrankungen
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози
TH19693B (th) การบำบัดทางชีวภาพโดยเอนไซม์
TH19693A (th) การบำบัดทางชีวภาพโดยเอนไซม์